14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

NMTR Predictions History

3 years ago
Barry Collett predicted that NMTR for 2021-03-01 is going

Rank:

3 years ago
JS predicted that NMTR for 2021-02-26 is going $1.60 (-3.61%)

3 years ago
cheryoung2001 predicted that NMTR for 2021-02-26 is going

Rank:

3 years ago
B4nxTV predicted that NMTR for 2021-02-26 is going

Rank:

3 years ago
JS predicted that NMTR for 2021-02-24 is going $1.62 (-11.48%)

3 years ago
JS predicted that NMTR for 2021-02-23 is going $1.87 (8.72%)

3 years ago
JS predicted that NMTR for 2021-02-17 is going $2.22 (14.43%)

3 years ago
Oscar Krogsgaard predicted that NMTR for 2021-02-17 is going $1.97 (-8.80%)

Rank:

3 years ago
JS predicted that NMTR for 2021-02-03 is going $1.42 (-19.32%)

3 years ago
Robert Eldridge predicted that NMTR for 2021-02-03 is going

Rank:
Click to get the best stock tips daily for free!

About 9 Meters Biopharma, Inc.

9 Meters Biopharma. 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as well as in Phase IIa clinical trial for treatment of multi-system inflammatory syndrome; and Vurolenatide... NMTR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT